AbbVie

Hello, Welcome to this week’s edition ofDispensed, Business Insider’s weekly healthcare newsletter. I’m back after a weekend of fun in Austin, Texas, where the weather was hot and...

AbbVie said on Tuesday that it’s buying Botox-maker Allergan in a $63 billion deal. The deal could generate as much as $183 million in fees for thebanks that worked on the deal, according to...

AbbVie is buying Botox-maker Allergan in a $63 billion deal,the companies said on Tuesday. The deal would combine AbbVie, which makes the blockbuster drug Humira, with Allergan, whichhas been facing...